T1	Participants 41 87	primary, nonmetastatic Ewing's sarcoma of bone
T2	Participants 133 216	264 children and adults with previously untreated localized Ewing's sarcoma of bone
T3	Participants 305 393	Children's Cancer Study Group, Southwest Oncology Group, and Cancer and Leukemia Group B
T4	Participants 652 698	All patients received RT to the primary lesion
